Clinical Trials Directory

Trials / Completed

CompletedNCT00000446

Drug Treatment for Alcoholics With Post-Traumatic Stress Disorder

Sertraline Treatment in Comorbid Post-Traumatic Stress Disorder and Alcoholism

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA) · NIH
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will investigate the use of sertraline (Zoloft) to decrease alcohol consumption and crime-related post-traumatic stress disorder in those individuals with both disorders. This will be a 12-week, placebo-controlled, double-blind outpatient trial. All subjects will receive cognitive behavioral therapy in addition to a placebo or sertraline. Comprehensive evaluation will be done at study entry; treatment termination; and 6, 9, and 12 months after study entry.

Conditions

Interventions

TypeNameDescription
DRUGsertraline (Zoloft)

Timeline

Completion
2000-12-01
First posted
1999-11-03
Last updated
2005-06-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00000446. Inclusion in this directory is not an endorsement.